MELISSIA BERRY: Open Payments
NPI 1538442835 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 83 payments from 17 companies in 2025. Trend: 2023 $2,155 · 2024 $2,195 · 2025 $2,028
Food & beverage: $1,968Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $415 |
| ABBVIE INC. | 16 | $367 |
| Mallinckrodt Hospital Products Inc. | 8 | $207 |
| Radius Health, Inc. | 10 | $179 |
| Fresenius Kabi USA, LLC | 5 | $132 |
| Novartis Pharmaceuticals Corporation | 4 | $108 |
| ANI Pharmaceuticals, Inc. | 4 | $96 |
| UCB, Inc. | 1 | $84 |
| AstraZeneca Pharmaceuticals LP | 1 | $79 |
| Organon LLC | 4 | $69 |
Products named: SKYRIZI, OTEZLA, ACTHAR, Tymlos, EVENITY, COSENTYX, Bimzelx, SAPHNELO.
Industry payments across TX — which companies pay providers there.
